Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Fungal Meningitis Outbreak Death Toll Reaches 58, as Concerns Continue June 6, 2013 Irvin Jackson Add Your Comments Nearly 60 people have now died as a result of a nationwide fungal meningitis outbreak linked to contaminated epidural steroid injections that were recalled late last year, and hundreds of other people face continuing effects of the infection, including a potential risk of relapsing.  According to the latest update provided by the U.S. Centers for Disease Control and Prevention (CDC) this month, at least 58 confirmed deaths and 745 fungal infections have been linked to injections mixed by the new defunct New England Compounding Center. The number of people killed has continued to increase, with at least three new deaths added to the tally since the CDC’s May report. Federal health regulators originally predicted after the outbreak surfaced in October 2012 that the number of illnesses should have leveled off late last year, as early information suggested that the risk of fungal meningitis may only extend several weeks, as opposed to several months. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION According to an April article published in the Journal of the American Medical Association (JAMA), experts now suggest that new fungal meningitis cases could continue to appear as long as a year after the outbreak first began A report published last week in the New England Journal of Medicine now suggests that even those who previously recovered from fungal meningitis may face continuing risks. Health officials outlined a case involving an 80 year-old man who was previously treated for four and a half months with anti-fungal therapy, and then relapsed and had to be hospitalized. The case raises questions about the adequacy of the current treatment guidelines, which already involve long and harsh antifungal treatments. The frontline drug the CDC has suggested is the antifungal medication voriconazole, with liposomal amphotericin added when needed. However, voriconazole has been linked to a number of side effects, including hallucinations, cognitive problems, nausea, memory loss and other problems. Some patients may improve after just three months on the drugs, while others may need to take it as long as six months. NECC faces a growing number of fungal meningitis outbreak lawsuits from victims. However, concerns exist about whether sufficient assets and insurance coverage will be available to properly compensate all of those infected. In the wake of the recall, NECC has declared bankruptcy. Clinics Provided Patient Lists to Avoid Regulator Scrutiny Over the months since the NECC fungal meningitis outbreak surfaced, information has highlighted how the compounding pharmacy was able to distribute its drugs so widely throughout the United States. While compounding pharmacies are supposed to only provide drugs to local hospitals on a per-prescription basis when that drug is not otherwise available, NECC distributed more than 17,000 epidural steroid injections to medical providers in dozens of different states throughout the country. A recent court filing suggests that at least one Nashville Clinic provided NECC with a list of patient names in order to avoid flak from regulators. However, the list was just cover, and had little bearing on which patients actually received the recalled epidural steroid injections. In the aftermath of the outbreak, the FDA and state agencies have cracked down on compounding pharmacies nationwide, and lawmakers have put forward new legislation to address the issue, with some suggesting a new class of compounding pharmacy be created that does mass drug production. However, this proposed legislation has also raised concerns from consumer groups, who indicate that it may create a class of drug manufacturers that would not have to meet current federal drug requirements. As the FDA increases inspection efforts at compounding pharmacies throughout the country, more and more facilities have had to recall all of their products due to problems with sterility. Most recently, on May 29, an Olympia Pharmacy drug recall was announced for all of that compounding pharmacy’s sterile drug products. Tags: Compounding Pharmacy, Epidural Steroid Injection, Fungal Meningitis, Infection Image Credit: | More Lawsuit Stories MDL Judge Orders Paraquat Lawsuit Settlement Update By June 11, 2025 May 16, 2025 Teen Gambling Problems Frequently Start With Online Sportsbook Betting: Study May 16, 2025 Court Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor May 15, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermEmailThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES MDL Judge Orders Paraquat Lawsuit Settlement Update By June 11, 2025 (Posted: yesterday) A federal judge has agreed to stay all case-specific discovery deadlines in Paraquat lawsuits, while the parties work to hammer out a settlement agreement to resolve thousands of claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSParaquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (04/16/2025)Appeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025) Court Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor (Posted: 2 days ago) As new Depo-Provera lawsuits continue to be filed, the judge presiding over the litigation has established key criteria for establishing proof of Depo-Provera use and medical documentation confirming a meningioma diagnosis. MORE ABOUT: DEPO-PROVERA LAWSUITDepo Shot Lawsuit Filed Over Serious Brain Tumor Injuries (05/07/2025)Lawsuit Alleges Depo-Provera Migraines, Headaches Led to Meningioma Brain Tumor Diagnosis (05/01/2025)Depo-Provera Hearing Loss Lawsuit Filed Over Brain Tumor Side Effects (04/22/2025) BioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (Posted: 3 days ago) A Massachusetts woman’s injuries from a failed tissue marker that was recently recalled led to the need for physical therapy, according to a BioZorb implant lawsuit. MORE ABOUT: BIOZORB LAWSUITFour Women File BioZorb Lawsuit Over Breast Tissue Marker Failures and Injuries (05/05/2025)Lawsuit Claims BioZorb Marker Caused Chronic Pain, Multiple Surgeries After Lumpectomy (04/14/2025)Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (04/02/2025)
Court Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor May 15, 2025
MDL Judge Orders Paraquat Lawsuit Settlement Update By June 11, 2025 (Posted: yesterday) A federal judge has agreed to stay all case-specific discovery deadlines in Paraquat lawsuits, while the parties work to hammer out a settlement agreement to resolve thousands of claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSParaquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (04/16/2025)Appeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025)
Court Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor (Posted: 2 days ago) As new Depo-Provera lawsuits continue to be filed, the judge presiding over the litigation has established key criteria for establishing proof of Depo-Provera use and medical documentation confirming a meningioma diagnosis. MORE ABOUT: DEPO-PROVERA LAWSUITDepo Shot Lawsuit Filed Over Serious Brain Tumor Injuries (05/07/2025)Lawsuit Alleges Depo-Provera Migraines, Headaches Led to Meningioma Brain Tumor Diagnosis (05/01/2025)Depo-Provera Hearing Loss Lawsuit Filed Over Brain Tumor Side Effects (04/22/2025)
BioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (Posted: 3 days ago) A Massachusetts woman’s injuries from a failed tissue marker that was recently recalled led to the need for physical therapy, according to a BioZorb implant lawsuit. MORE ABOUT: BIOZORB LAWSUITFour Women File BioZorb Lawsuit Over Breast Tissue Marker Failures and Injuries (05/05/2025)Lawsuit Claims BioZorb Marker Caused Chronic Pain, Multiple Surgeries After Lumpectomy (04/14/2025)Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (04/02/2025)